Renato Umeton

Hasan Kassem, Orion Banks, Omar Benjelloun et al.

Decentralized AI systems, such as federated learning, can play a critical role in further unlocking AI asset marketplaces (e.g., healthcare data marketplaces) thanks to increased asset privacy protection. Unlocking this big potential necessitates governance mechanisms that are transparent, scalable, and verifiable. However current governance approaches rely on bespoke, infrastructure-specific policies that hinder asset interoperability and trust among systems. We are proposing a Technical Policy Blueprint that encodes governance requirements as policy-as-code objects and separates asset policy verification from asset policy enforcement. In this architecture the Policy Engine verifies evidence (e.g., identities, signatures, payments, trusted-hardware attestations) and issues capability packages. Asset Guardians (e.g. data guardians, model guardians, computation guardians, etc.) enforce access or execution solely based on these capability packages. This core concept of decoupling policy processing from capabilities enables governance to evolve without reconfiguring AI infrastructure, thus creating an approach that is transparent, auditable, and resilient to change.

Rafi Al Attrach, Pedro Moreira, Rajna Fani et al.

As ever-larger clinical datasets become available, they have the potential to unlock unprecedented opportunities for medical research. Foremost among them is Medical Information Mart for Intensive Care (MIMIC-IV), the world's largest open-source EHR database. However, the inherent complexity of these datasets, particularly the need for sophisticated querying skills and the need to understand the underlying clinical settings, often presents a significant barrier to their effective use. M3 lowers the technical barrier to understanding and querying MIMIC-IV data. With a single command it retrieves MIMIC-IV from PhysioNet, launches a local SQLite instance (or hooks into the hosted BigQuery), and-via the Model Context Protocol (MCP)-lets researchers converse with the database in plain English. Ask a clinical question in natural language; M3 uses a language model to translate it into SQL, executes the query against the MIMIC-IV dataset, and returns structured results alongside the underlying query for verifiability and reproducibility. Demonstrations show that minutes of dialogue with M3 yield the kind of nuanced cohort analyses that once demanded hours of handcrafted SQL and relied on understanding the complexities of clinical workflows. By simplifying access, M3 invites the broader research community to mine clinical critical-care data and accelerates the translation of raw records into actionable insight.

Mohamed Omar, Giuseppe Nicolo Fanelli, Fabio Socciarelli et al.

Conventional histopathology has long been essential for disease diagnosis, relying on visual inspection of tissue sections. Immunohistochemistry aids in detecting specific biomarkers but is limited by its single-marker approach, restricting its ability to capture the full tissue environment. The advent of multiplexed imaging technologies, like multiplexed immunofluorescence and spatial transcriptomics, allows for simultaneous visualization of multiple biomarkers in a single section, enhancing morphological data with molecular and spatial information. This provides a more comprehensive view of the tissue microenvironment, cellular interactions, and disease mechanisms - crucial for understanding disease progression, prognosis, and treatment response. However, the extensive data from multiplexed imaging necessitates sophisticated computational methods for preprocessing, segmentation, feature extraction, and spatial analysis. These tools are vital for managing large, multidimensional datasets, converting raw imaging data into actionable insights. By automating labor-intensive tasks and enhancing reproducibility and accuracy, computational tools are pivotal in diagnostics and research. This review explores the current landscape of multiplexed imaging in pathology, detailing workflows and key technologies like PathML, an AI-powered platform that streamlines image analysis, making complex dataset interpretation accessible for clinical and research settings.

Advait Gosai, Arun Kavishwar, Stephanie L. McNamara et al.

Recent work has shown promising performance of frontier large language models (LLMs) and their multimodal counterparts in medical quizzes and diagnostic tasks, highlighting their potential for broad clinical utility given their accessible, general-purpose nature. However, beyond diagnosis, a fundamental aspect of medical image interpretation is the ability to localize pathological findings. Evaluating localization not only has clinical and educational relevance but also provides insight into a model's spatial understanding of anatomy and disease. Here, we systematically assess two general-purpose MLLMs (GPT-4 and GPT-5) and a domain-specific model (MedGemma) in their ability to localize pathologies on chest radiographs, using a prompting pipeline that overlays a spatial grid and elicits coordinate-based predictions. Averaged across nine pathologies in the CheXlocalize dataset, GPT-5 exhibited a localization accuracy of 49.7%, followed by GPT-4 (39.1%) and MedGemma (17.7%), all lower than a task-specific CNN baseline (59.9%) and a radiologist benchmark (80.1%). Despite modest performance, error analysis revealed that GPT-5's predictions were largely in anatomically plausible regions, just not always precisely localized. GPT-4 performed well on pathologies with fixed anatomical locations, but struggled with spatially variable findings and exhibited anatomically implausible predictions more frequently. MedGemma demonstrated the lowest performance on all pathologies, but showed improvements when provided examples through few shot prompting. Our findings highlight both the promise and limitations of current MLLMs in medical imaging and underscore the importance of integrating them with task-specific tools for reliable use.

James Wen, Sahil Nalawade, Zhiwei Liang et al. · deepmind, harvard

Background: Generative artificial intelligence (AI) deployment in academic medical settings raises copyright compliance concerns. Dana-Farber Cancer Institute implemented GPT4DFCI, an internal generative AI tool utilizing OpenAI models, that is approved for enterprise use in research and operations. Given (1) the exceptionally broad adoption of the tool in our organization, (2) our research mission, and (3) the shared responsibility model required to benefit from Customer Copyright Commitment in Azure OpenAI Service products, we deemed rigorous copyright compliance testing necessary. Case Description: We conducted a structured red teaming exercise in Nov. 2024, with 42 participants from academic, industry, and government institutions. Four teams attempted to extract copyrighted content from GPT4DFCI across four domains: literary works, news articles, scientific publications, and access-restricted clinical notes. Teams successfully extracted verbatim book dedications and near-exact passages through various strategies. News article extraction failed despite jailbreak attempts. Scientific article reproduction yielded only high-level summaries. Clinical note testing revealed appropriate privacy safeguards. Discussion: The successful extraction of literary content indicates potential copyrighted material presence in training data, necessitating inference-time filtering. Differential success rates across content types suggest varying protective mechanisms. The event led to implementation of a copyright-specific meta-prompt in GPT4DFCI; this mitigation has been in production since Jan. 2025. Conclusion: Systematic red teaming revealed specific vulnerabilities in generative AI copyright compliance, leading to concrete mitigation strategies. Academic medical institutions deploying generative AI should implement continuous testing protocols to ensure legal and ethical compliance.

Alexandros Karargyris, Renato Umeton, Micah J. Sheller et al.

Medical AI has tremendous potential to advance healthcare by supporting the evidence-based practice of medicine, personalizing patient treatment, reducing costs, and improving provider and patient experience. We argue that unlocking this potential requires a systematic way to measure the performance of medical AI models on large-scale heterogeneous data. To meet this need, we are building MedPerf, an open framework for benchmarking machine learning in the medical domain. MedPerf will enable federated evaluation in which models are securely distributed to different facilities for evaluation, thereby empowering healthcare organizations to assess and verify the performance of AI models in an efficient and human-supervised process, while prioritizing privacy. We describe the current challenges healthcare and AI communities face, the need for an open platform, the design philosophy of MedPerf, its current implementation status, and our roadmap. We call for researchers and organizations to join us in creating the MedPerf open benchmarking platform.